我们对20例巨块型宫颈癌病人实施了术前新辅助化疗(neoadjuvant chemotherapy, NACT)，取得了较好的治疗效果，现报道如下：1 资料与方法1.1 一般资料自2002年，在我院妇产科治疗的宫...
基于16个网页-相关网页
目的分析宫颈癌术前新辅助化疗—动脉灌注的疗效。
Objective To analyze the therapeutic effect of arterial perfusion and neoadjuvant chemotherapy on cervical cancer.
结论术前新辅助化疗可提高食管癌手术的切除率并不增加术后并发症。
Conclusion Patients of esophageal carcinoma, neoadjuvant chemotherapy can increased the resectability rate, meanwhile cannot increase postoperative complications and mortality.
目的探讨术前新辅助化疗对乳腺癌的疗效及提高患者术后生存率的作用。
To explore the effect of new auxiliary chemotherapy before operation on treating local mammary cancer of late stage and prolonging the life of the cancer patients.
应用推荐